Sage Therapeutics Inc (SAGE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

215 FIRST STREET CAMBRIDGE, MA 02142

Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions.

Data based on most recent fiscal year report
Market Cap5.886 Billion Shares Outstanding41.05 Million Avg Volume937.737 Thousand
1-Yr BETA vs S&P TR Current Ratio10.11 Quick Ratio10.11
View SEC Filings from SAGE instead.
Q4 2018 All Institutions Hedge Funds 1
To trade SAGE now:
Filers who had this stock in their top 10: 6 3 (0.3%)
13F Filers holding this stock: 243 37 (3.67%)
Aggregate 13F shares on 12/31/2018: 49.686 Million 3.91 Million
Aggregate 13F shares on 09/30/2018: 48.695 Million 5.103 Million
Percent change: 2.04% -23.38%
Funds creating new positions: 31 9
Funds Adding to an existing position: 89 8
Funds closing out their position: 58 20
Funds reducing their position: 85 16
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SAGE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

111.6 Thousand total shares from 20 transactions

Exercise Derivative Conversion (M)

12.2 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

IGUCHI KIMI CFO & TREASURER

6,136 2019-03-08 8

GOLUMBESKI GEORGE

  • Director
0 2019-03-04 2

FRATES JAMES M SVP, ALKS INC; CFO ALKS

  • Officer
195,925 2019-03-01 4

PAUL STEVEN M

1,039,577 2019-03-01 5

KANES STEPHEN CHIEF MEDICAL OFFICER

0 2019-02-13 4

JONAS JEFFREY M PRESIDENT & CEO

0 2019-02-13 4

ROBICHAUD ALBERT CHIEF SCIENTIFIC OFFICER

0 2019-02-13 4

COOK ANNE MARIE SVP, GC & SECRETARY

0 2019-02-13 3

CLOONAN MICHAEL CHIEF BUSINESS OFFICER

0 2019-02-13 2

STARR KEVIN P

  • Director
302,817 2019-02-12 3

BARRETT ELIZABETH

0 2019-01-22 2

GERMANO GENO J

0 2019-01-03 2

PIEN HOWARD H

  • Director
2,929 2019-01-02 0

COLA MICHAEL F PRESIDENT AND CEO

  • Officer
  • Director
0 2018-06-14 1

NELSEN ROBERT

  • Director
  • 10% Owner
0 2018-06-13 0

NAYAK ASHA

0 2018-06-06 1

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2018-03-07 0

ANDERSON THOMAS SEE REMARKS

0 2017-02-06 0

ARCH VENTURE FUND VII LP

ARCH VENTURE PARTNERS VII, L.P.

ARCH VENTURE PARTNERS VII, LLC

CRANDELL KEITH

BYBEE CLINTON

  • 10% Owner
4,637,137 2016-07-06 0

STEBEN KENNETH E CEO AND TRUSTEE

  • Officer
  • Director
  • 10% Owner
100,000 2015-04-01 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

IGUCHI KIMI CFO & TREASURER

2019-03-08 M 4,723 d 0 6,136.00 direct

IGUCHI KIMI CFO & TREASURER

2019-03-08 M 4,723 $0.45 a 6,136 6,136.00 direct

PAUL STEVEN M see footnote (2)

2019-03-01 S 700 $161.00 d 192,600 1,039,577.00 indirect

PAUL STEVEN M see footnote (5)

2019-03-01 S 700 $161.00 d 191,400 1,039,577.00 indirect

IGUCHI KIMI CFO & TREASURER

2019-03-01 S 25,563 $156.93 d 1,413 1,413.00 direct yes

PAUL STEVEN M see footnote (4)

2019-03-01 S 500 $161.00 d 192,100 1,039,577.00 indirect

PAUL STEVEN M see footnote (6)

2019-03-01 S 700 $161.00 d 190,700 1,039,577.00 indirect

PAUL STEVEN M see footnote (9)

2019-02-25 G 30,600 a 162,700 1,268,272.00 indirect

PAUL STEVEN M see footnote (6)

2019-02-25 G 122,400 d 119,295 1,268,272.00 indirect

PAUL STEVEN M see footnote (3)

2019-02-25 S 500 $161.00 d 71,900 1,268,272.00 indirect

PAUL STEVEN M see footnote (8)

2019-02-25 G 30,600 a 132,100 1,268,272.00 indirect

PAUL STEVEN M see footnote (5)

2019-02-25 S 500 $161.00 d 70,900 1,268,272.00 indirect

PAUL STEVEN M see footnote (2)

2019-02-25 S 500 $161.00 d 72,400 1,268,272.00 indirect

PAUL STEVEN M see footnote (10)

2019-02-25 G 30,600 a 193,300 1,268,272.00 indirect

PAUL STEVEN M see footnote (7)

2019-02-25 G 30,600 a 101,500 1,268,272.00 indirect

PAUL STEVEN M see footnote (4)

2019-02-25 S 500 $161.00 d 71,400 1,268,272.00 indirect

PAUL STEVEN M see footnote (13)

2019-02-19 S 643 $161.37 d 73,100 566,763.00 indirect

PAUL STEVEN M see footnote (11)

2019-02-19 S 500 $161.62 d 73,743 566,763.00 indirect

PAUL STEVEN M see footnote (15)

2019-02-19 S 200 $162.00 d 72,900 566,763.00 indirect

PAUL STEVEN M see footnote (10)

2019-02-19 S 200 $162.00 d 74,243 566,763.00 indirect

PAUL STEVEN M see footnote (9)

2019-02-15 S 12,388 $161.02 d 74,443 566,763.00 indirect

PAUL STEVEN M see footnote (3)

2019-02-15 S 12,519 $161.02 d 111,385 566,763.00 indirect

PAUL STEVEN M see footnote (7)

2019-02-15 S 12,044 $161.02 d 86,831 566,763.00 indirect

PAUL STEVEN M see footnote (5)

2019-02-15 S 12,510 $161.02 d 98,875 566,763.00 indirect

IGUCHI KIMI CFO & TREASURER

2019-02-13 A 19,000 a 19,000 0.00 direct

JONAS JEFFREY M PRESIDENT & CEO

2019-02-13 A 50,000 a 50,000 0.00 direct

KANES STEPHEN CHIEF MEDICAL OFFICER

2019-02-13 A 19,000 a 19,000 0.00 direct

CLOONAN MICHAEL CHIEF BUSINESS OFFICER

2019-02-13 A 24,500 a 24,500 0.00 direct

ROBICHAUD ALBERT CHIEF SCIENTIFIC OFFICER

2019-02-13 A 19,000 a 19,000 0.00 direct

COOK ANNE MARIE SVP, GC & SECRETARY

2019-02-13 A 19,000 a 19,000 0.00 direct

KANES STEPHEN CHIEF MEDICAL OFFICER

2019-02-08 S 22,948 $150.00 d 941 941.00 direct yes

PAUL STEVEN M see footnote (1)

2019-02-01 G 241,695 a 241,695 566,763.00 indirect

PAUL STEVEN M

2019-02-01 G 241,695 d 272,777 566,763.00 direct

FRATES JAMES M

2019-01-23 M 7,500 $8.92 a 11,735 4,235.00 direct

FRATES JAMES M

2019-01-23 M 7,500 d 9,309 4,235.00 direct

FRATES JAMES M

2019-01-23 S 7,500 $134.81 d 4,235 4,235.00 direct yes

BARRETT ELIZABETH

2019-01-22 A 20,000 a 20,000 0.00 direct

GOLUMBESKI GEORGE

2019-01-22 A 20,000 a 20,000 0.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments